169 related articles for article (PubMed ID: 35708089)
1. Increased Circulating Pentraxin 3 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
Guan SY; Chen Y; Shao M; Yang H; Xu W; Shuai Z; Zhao H; Zhao D; Pan F
Curr Pharm Des; 2022; 28(27):2260-2269. PubMed ID: 35708089
[TBL] [Abstract][Full Text] [Related]
2. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
Asanuma YF; Aizaki Y; Noma H; Yokota K; Matsuda M; Kozu N; Takebayashi Y; Nakatani H; Hasunuma T; Kawai S; Mimura T
Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
[No Abstract] [Full Text] [Related]
3. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
[TBL] [Abstract][Full Text] [Related]
4. Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.
Liou LB; Tsai WP; Chang CJ; Chao WJ; Chen MH
PLoS One; 2013; 8(1):e55346. PubMed ID: 23383162
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: A systematic review and meta-analysis.
Wen X; Hou R; Xu K; Han Y; Hu J; Zhang Y; Su Y; Gao J; Zhang G; Zhang L
PLoS One; 2021; 16(2):e0245612. PubMed ID: 33529185
[TBL] [Abstract][Full Text] [Related]
6. Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.
Sharma A; Khan R; Gupta N; Sharma A; Zaheer MS; Abbas M; Khan SA
Clin Chim Acta; 2018 May; 480():65-70. PubMed ID: 29408170
[TBL] [Abstract][Full Text] [Related]
7. Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response.
Boutet MA; Nerviani A; Lliso-Ribera G; Leone R; Sironi M; Hands R; Rivellese F; Del Prete A; Goldmann K; Lewis MJ; Mantovani A; Bottazzi B; Pitzalis C
Front Immunol; 2021; 12():686795. PubMed ID: 34248970
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Zhang M; Yin J; Zhang X
PLoS One; 2023; 18(6):e0286191. PubMed ID: 37352174
[TBL] [Abstract][Full Text] [Related]
9. Association of Pentraxin 3 with Autoimmune Diseases: A Systematic Review and Meta-Analysis.
Huang XL; Zhang L; Duan Y; Wang YJ; Wang J
Arch Med Res; 2016 Apr; 47(3):223-31. PubMed ID: 27255354
[TBL] [Abstract][Full Text] [Related]
10. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Saxne T; Manivel VA; Lysholm J; Knight A; Rönnelid J
Scand J Rheumatol; 2017 Sep; 46(5):346-352. PubMed ID: 27973973
[TBL] [Abstract][Full Text] [Related]
11. Association between serum amyloid A and rheumatoid arthritis: A systematic review and meta-analysis.
Zhou J; Dai Y; Lin Y; Chen K
Semin Arthritis Rheum; 2022 Feb; 52():151943. PubMed ID: 35027248
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Ke Y; Wu K; Shen C; Zhu Y; Xu C; Li Q; Hu J; Liu S
Infect Dis Ther; 2023 Jan; 12(1):67-80. PubMed ID: 36443545
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
15. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
Wang P; Li S; Liu LN; Lv TT; Li XM; Li XP; Pan HF
Clin Rheumatol; 2017 Oct; 36(10):2193-2200. PubMed ID: 28698901
[TBL] [Abstract][Full Text] [Related]
16. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
17. Association between pentraxin-3 and the risk of preeclampsia: A meta-analysis.
Xiong Z; Wang X; Jiang S; Jin M; Chen W
Medicine (Baltimore); 2020 Jun; 99(26):e20744. PubMed ID: 32590749
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past.
Qiu C; Han Y; Zhang H; Liu T; Hou H; Luo D; Yu M; Bian K; Zhao Y; Xiao X
Int J Med Sci; 2021; 18(8):1886-1898. PubMed ID: 33746606
[TBL] [Abstract][Full Text] [Related]
19. Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis.
Lee YH; Bae SC
Z Rheumatol; 2016 Dec; 75(10):1021-1027. PubMed ID: 26820722
[TBL] [Abstract][Full Text] [Related]
20. Circulating leptin and its correlation with rheumatoid arthritis activity: a meta-analysis.
Lee YH; Song GG
J Rheum Dis; 2023 Apr; 30(2):116-125. PubMed ID: 37483475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
